Bajaj Healthcare Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Mar 2021
Auditor and Management Disclosures and Notes for the annual results dated 31 Mar 2021
1. The above Financial Results have been reviewed by the Audit Committee and subsequently approved by Board of Directors at their respective meetings held on June 9, 2021.
2. As the Company was listed in SME segment of BSE Lid as on 31st March 2019 and migrated to Main Board on 29th May 2089, Ind-AS is applicable from 1st April, 2020. Hence, the company has adopted Indian Accounting Standard ("Ind AS") as notified under Section 133 of the Companies Act, 2013 ("the Act") read with the Companies (Indian Accounting Standards) Rules, 2015 for first time from April 1, 2020. The above financial results have been prepared in accordance with principles as laid down in Ind AS-34 - Interim Financial Reporting.
c) The financial results for the Quarter and Year ending 31st March 2021 have been subjected to limited review by the statutory auditors of the Company. The restated comparative figures under IND -AS prepared by the Management are after exercising necessary due diligence to ensure financial results reflects true and fair view of Company's affairs in Indian Accounting Standard (Ind AS") for Quarter and Year End figures for 31st March 2020 and are not subject to Review of the Statutory Auditors. The financial results for such period prepared under IGAAP framework) were reviewed by Statutory Auditors.
4. Reconciliation of Net profit and Reserves as reported under generally accepted accounting principles (GAAP) and as per IND AS is given below:
For Table, kindly refer Corporate Announcements on www.bseindia.com.
5. The Statement as per IND AS - 108 on segment reporting is given as Annexure- A,
6. Figures of previous period have been regrouped / reclassified, wherever necessary, to make them comparable and to conform with current period classification.